Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | PTC Therapeutics, Inc. PTCT | BlackRock Inc. BLK | 6,274,384 8.000% | -1,394,487 (-18.18%) | Filing History |
| 2025-02-14 5:18 pm Sale | 2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT | ARMISTICE CAPITAL LLC | 6,378,000 8.270% | -856,898 (-11.84%) | Filing History |
| 2025-02-14 08:35 am Sale | 2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT | Camber Capital Management LLC | 3,200,000 4.150% | -800,000 (-20.00%) | Filing History |
| 2025-02-10 10:25 am Sale | 2024-12-31 | 13G | PTC Therapeutics, Inc. PTCT | WELLINGTON MANAGEMENT GROUP LLP | 4,787,123 6.200% | -3,105,676 (-39.35%) | Filing History |
| 2024-11-14 5:22 pm Purchase | 2024-09-30 | 13G | PTC Therapeutics, Inc. PTCT | ARMISTICE CAPITAL LLC | 7,234,898 9.400% | 370,898 (+5.40%) | Filing History |
| 2024-11-08 10:52 am Sale | 2024-09-30 | 13G | PTC Therapeutics, Inc. PTCT | WELLINGTON MANAGEMENT GROUP LLP | 7,892,799 10.260% | -1,923,804 (-19.60%) | Filing History |
| 2024-10-18 10:57 am Sale | 2024-09-30 | 13G | PTC Therapeutics, Inc. PTCT | STATE STREET CORP STT | 2,899,040 3.800% | -1,734,915 (-37.44%) | Filing History |
| 2024-08-27 4:45 pm Sale | 2024-08-23 | 13D | MRI INTERVENTIONS INC MRIC | PTC THERAPEUTICS INC. PTCT | 894,578 3.240% | -1,666,667 (-65.07%) | Filing History |
| 2024-02-14 3:50 pm Purchase | 2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT | ARMISTICE CAPITAL LLC | 6,864,000 9.100% | 6,864,000 (New Position) | Filing History |
| 2024-02-14 07:13 am Purchase | 2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT | RTW INVESTMENTS LLC | 7,423,970 9.800% | 1,808,583 (+32.21%) | Filing History |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | PTC Therapeutics, Inc. PTCT | VANGUARD GROUP INC | 8,800,843 11.660% | 1,461,323 (+19.91%) | Filing History |
| 2024-02-08 10:17 am Purchase | 2023-12-29 | 13G | PTC Therapeutics, Inc. PTCT | WELLINGTON MANAGEMENT GROUP LLP | 9,816,603 13.010% | 2,385,696 (+32.11%) | Filing History |
| 2024-01-24 1:11 pm Purchase | 2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT | STATE STREET CORP STT | 4,633,955 6.140% | 2,235,641 (+93.22%) | Filing History |
| 2024-01-10 08:53 am Sale | 2024-01-09 | 13G | PTC Therapeutics, Inc. PTCT | FMR LLC | 1,814,421 2.404% | -4,617,429 (-71.79%) | Filing History |
| 2024-01-08 4:35 pm Purchase | 2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT | BlackRock Inc. BLK | 7,668,871 10.200% | 1,028,017 (+15.48%) | Filing History |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | PTC Therapeutics, Inc. PTCT | FMR LLC | 6,431,850 8.523% | -4,350,456 (-40.35%) | Filing History |
| 2023-10-30 09:05 am Purchase | 2023-10-19 | 13G | PTC Therapeutics, Inc. PTCT | Camber Capital Management LLC | 4,000,000 5.310% | 4,000,000 (New Position) | Filing History |
| 2023-06-15 4:41 pm Sale | 2023-06-13 | 13D | MRI INTERVENTIONS INC MRIC | PTC THERAPEUTICS INC. PTCT | 2,561,245 9.760% | -400,000 (-13.51%) | Filing History |
| 2023-02-14 10:02 am Purchase | 2022-12-31 | 13G | PTC Therapeutics, Inc. PTCT | RTW INVESTMENTS LLC | 5,615,387 7.700% | 321,421 (+6.07%) | Filing History |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | PTC Therapeutics, Inc. PTCT | FMR LLC | 10,782,306 14.999% | 177,621 (+1.67%) | Filing History |